Inhibition of Escherichia coli-induced meningitis by carboxyfullerence

Antimicrob Agents Chemother. 1999 Sep;43(9):2273-7. doi: 10.1128/AAC.43.9.2273.

Abstract

The effect of a water-soluble malonic acid derivative of carboxyfullerence (C60) against Escherichia coli-induced meningitis was tested. C60 can protect the mice from E. coli-induced death in a dose-dependent manner. C60 administered intraperitoneally as late as 9 h after E. coli injection was still protective. The C60-treated mice had less tumor necrosis factor alpha and interleukin-1beta production by staining of brain tissue compared to the levels of production for nontreated mice. The E. coli-induced increases in blood-brain barrier permeability and inflammatory neutrophilic infiltration were also inhibited. These data suggest that C60 is a potentially therapeutic agent for bacterial meningitis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents / therapeutic use*
  • Blood-Brain Barrier / drug effects
  • Brain / pathology
  • Carbon / therapeutic use*
  • Escherichia coli Infections / drug therapy*
  • Escherichia coli Infections / pathology
  • Female
  • Fullerenes*
  • Injections, Intraperitoneal
  • Interleukin-1 / biosynthesis
  • Meningitis, Bacterial / drug therapy*
  • Meningitis, Bacterial / pathology
  • Mice
  • Tumor Necrosis Factor-alpha / biosynthesis

Substances

  • Antiviral Agents
  • Fullerenes
  • Interleukin-1
  • Tumor Necrosis Factor-alpha
  • Carbon
  • fullerene C60